نتایج جستجو برای: apoptosis memantine

تعداد نتایج: 157062  

Journal: :The Journal of pharmacology and experimental therapeutics 1997
P Popik W Danysz

The present study focused on the effects of 1-amino-3,5-dimethyladamantane (memantine), a clinically used, low-affinity N-methyl-D-aspartate channel blocker, on the motivational impact of morphine and morphine withdrawal syndrome. Memantine (7.5 mg/kg) inhibited the acquisition as well as the expression of morphine-induced conditioned place preference. However, memantine did not affect signific...

2014
Zohreh Sadat Nasihatkon Maryam Khosravi Zahra Bourbour Hedayat Sahraei Mina Ranjbaran Seyedeh Maryam Hassantash Mohammad Sahraei Kefayat Baghlani

BACKGROUND Stress and its consequences are among the causes of accidents. OBJECTIVE The effects of intraventral tegmental area (I-VTA) memantine on the plasma corticosterone and eating parameters disturbance induced by acute stress were investigated. METHODS Male Wistar rats (W: 250-300 g) were divided into control and experiential groups, each of which received memantine either intra-VTA o...

Journal: :Journal of gerontological nursing 2015

Actavis and Adamas Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration has approved the New Drug Application for NamzaricTM for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on memantine hydrochloride and donepezil hydrochloride. Namzaric will be available in two dosage strengths: 28/10 mg (memantine extended release/donepezi...

Journal: :The Journal of pharmacology and experimental therapeutics 2005
Huei-Sheng Vincent Chen Stuart A Lipton

Unlike other N-methyl-D-aspartate receptor (NMDAR) antagonists, clinical trials have shown that memantine is clinically tolerated and effective in the treatment of Alzheimer's disease. The mechanism for memantine tolerability, however, remains contentious but may be partly explained by its uncompetitive antagonism. The specific site of memantine block in the NMDAR channel interacts with magnesi...

2017
Taro Kishi Shinji Matsunaga Nakao Iwata

BACKGROUND Memantine is effective in the treatment of behavioral disturbances in patients with Alzheimer's disease. It has not yet been fully determined which behavioral disturbances respond best to memantine. METHODS We conducted a meta-analysis of memantine vs control (placebo or usual care) for the treatment of individual behavioral disturbances (delusion, hallucination, agitation/aggressi...

Journal: :The Lancet. Neurology 2013
Adam L Boxer David S Knopman Daniel I Kaufer Murray Grossman Chiadi Onyike Neill Graf-Radford Mario Mendez Diana Kerwin Alan Lerner Chuang-Kuo Wu Mary Koestler Jill Shapira Kathryn Sullivan Kristen Klepac Kristine Lipowski Jerin Ullah Scott Fields Joel H Kramer Jennifer Merrilees John Neuhaus M Marsel Mesulam Bruce L Miller

BACKGROUND Memantine has been used off-label to treat frontotemporal lobar degeneration (FTD). A previous 26-week open-label study suggested a transient, modest benefit on neuropsychiatric symptoms as measured by the neuropsychiatric inventory (NPI). We aimed to determine whether memantine is an effective treatment for FTD. METHODS We did a randomised, parallel group, double-blind, placebo-co...

2015
Chih-Yuan Huang Liang-Chao Wang Yan-Shen Shan Chia-Hsin Pan Kuen-Jer Tsai Xiaofeng Jia

Delayed cerebral vasospasm is an important pathological feature of subarachnoid hemorrhage (SAH). The cause of vasospasm is multifactorial. Impairs nitric oxide availability and endothelial nitric oxide synthase (eNOS) dysfunction has been reported to underlie vasospasm. Memantine, a low-affinity uncompetitive N-methyl-d-aspartate (NMDA) blocker has been proven to reduce early brain injury afte...

Journal: :physiology and pharmacology 0
nahid sarahian dept. of biology, islamic azad university, north tehran branch, tehran, iran hedayat sahraei neuroscience research center, baqiyatallah (a.s.) university of medical sciences, tehran, iran homeira zardooz dept. of physiology, school of medicine, shahid beheshti university of medical sciences, tehran, iran hengameh ali-beik dept. of biology, islamic azad university, north tehran branch, tehran, iran bahareh sadeghi dept. of biology, islamic azad university, north tehran branch, tehran, iran taherehsadat javadifar neuroscience research center, baqiyatallah (a.s.) university of medical sciences, tehran, iran

introduction: in this study, the effect of memantine administration into the nucleus accumbens on the metabolic changes induced by acute stress in female mice was evaluated. methods: intra-accumbens unilateral or bilateral canulation was performed. one week after recovery, a group of animals were given memantine (1, 0.5, and 0.1 μg/mouse) five min before stress induction intra-accumbally, and t...

Introduction: Ischemic stroke is amongst the top four causes of mortality and the leading cause of disability in the world. The aim of this study was to evaluate the efficacy of a high dose memantine on neurological function of patients with ischemic stroke.Methods: In a randomized, 2 armed, open-label study, patients with mild to moderate cerebral thromboembolic event (CTEE) who admitted to Im...

Background and purpose: Memantine is a medication used to treat moderate to severe Alzheimer’s disease. Memantine targeting the glutamatergic system specifically N-Methyl-D-Aspartate offer a novel approach in treatment of psychiatric disorders such as schizophrenia and schizoaffective disorder. The purpose of this study was to evaluate the efficacy and safety of memantine in combination with an...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید